Year: 2018
Type: article
Abstract: Antimicrobial resistance is one of the greatest challenges of the 21st century. Evaluation of the public health burden of antimicrobial resistance, which is needed to drive policy interventions, is done through estimates of clinical benchmarks (mainly morbidity and crude mortality) and economic indicators (direct costs, use of resources, and drug expenditures). Most of these estimates are restricted to high-income countries and retrieve data to fit the computation models from national surveillance of clinical samples, prevalence or incidence surveys, and retrospective cohorts.
Source: The Lancet Infectious Diseases
Authors: Evelina Tacconelli, Maria Diletta Pezzani
Institution: University of Verona
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $7,280
OpenAlex ID: W2899724706
